Next Article in Journal
The p97 Inhibitor UPCDC-30245 Blocks Endo-Lysosomal Degradation
Previous Article in Journal
Mineralocorticoid Receptor Antagonist (Potassium Canrenoate) Does Not Influence Outcome in the Treatment of COVID-19-Associated Pneumonia and Fibrosis—A Randomized Placebo Controlled Clinical Trial
 
 
Article

Article Versions Notes

Pharmaceuticals 2022, 15(2), 201; https://doi.org/10.3390/ph15020201
Action Date Notes Link
article pdf uploaded. 7 February 2022 12:31 CET Version of Record https://www.mdpi.com/1424-8247/15/2/201/pdf-vor
article supplementary file uploaded. 7 February 2022 12:31 CET - https://www.mdpi.com/1424-8247/15/2/201#supplementary
article xml file uploaded 10 February 2022 07:02 CET Original file -
article xml uploaded. 10 February 2022 07:02 CET Update -
article pdf uploaded. 10 February 2022 07:02 CET Updated version of record https://www.mdpi.com/1424-8247/15/2/201/pdf-vor
article html file updated 10 February 2022 07:03 CET Original file -
article pdf uploaded. 9 March 2022 04:16 CET Updated version of record https://www.mdpi.com/1424-8247/15/2/201/pdf
article xml uploaded. 9 March 2022 04:16 CET Update https://www.mdpi.com/1424-8247/15/2/201/xml
article html file updated 9 March 2022 04:17 CET Update -
article html file updated 31 July 2022 11:38 CEST Update -
article html file updated 15 May 2023 13:33 CEST Update https://www.mdpi.com/1424-8247/15/2/201/html
Back to TopTop